Madeleine Pharmaceuticals' Seed VC Round

Madeleine Pharmaceuticals raised a round of funding on June 09, 2009. Investors include BioInnovation SA.

Madeleine Pharmaceuticals was spun-out from Hospira's Adelaide operations. Madeleine will commercialise and manufacture a novel treatment for congestive heart failure based on a naturally occurring pe…

Articles about Madeleine Pharmaceuticals' Seed VC Round: